Related Experiment Video
Updated: Jul 12, 2026
09:06
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNAs in tumorigenesis: a primer
Wenyong Zhang1, James E Dahlberg, Wayne Tam
1Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, Starr 711A, 525 East 68th St., New York, NY 10021, USA.
The American Journal of Pathology
|August 29, 2007
Summary
MicroRNAs (miRNAs) are small RNA molecules regulating genes. Their abnormalities are crucial in cancer, offering new diagnostic and therapeutic possibilities for oncologists.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) are noncoding small RNAs regulating gene expression.
- Their discovery has opened new avenues in cancer research.
- Abnormal miRNA expression is increasingly linked to cancer development.
Purpose of the Study:
- To review the basics of miRNA biology.
- To explore the emerging role of miRNAs in cancer pathogenesis, classification, and prognostication.
- To highlight specific miRNA involvement in various tumor types.
Main Methods:
- Review of current scientific literature on miRNA biology and oncology.
- Analysis of miRNA functions in cancer development.
- Examination of miRNA roles in cancer classification and prognosis.
Main Results:
- miRNA abnormalities are a significant factor in cancer.
- Specific miRNAs are implicated in the development of different cancers.
- miRNAs show potential as biomarkers for cancer classification and prognosis.
Conclusions:
- miRNA research offers significant promise for understanding cancer and developing new therapies.
- Pathologists need to be informed about miRNA's role in oncology.
- Targeting miRNAs presents a novel therapeutic strategy for cancer treatment.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...